Bavarian Nordic A/S (BAVA.CO)
BAVA.CO on Copenhagen Stock Exchange
151.95DKK
15 Feb 2019
151.95DKK
15 Feb 2019
Change (% chg)
kr.1.20 (+0.80%)
kr.1.20 (+0.80%)
Prev Close
kr.150.75
kr.150.75
Open
kr.150.00
kr.150.00
Day's High
kr.151.95
kr.151.95
Day's Low
kr.148.45
kr.148.45
Volume
47,157
47,157
Avg. Vol
187,820
187,820
52-wk High
kr.257.60
kr.257.60
52-wk Low
kr.117.75
kr.117.75
About
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)
Overall
Beta: | 1.27 |
Market Cap(Mil.): | kr.9,290.57 |
Shares Outstanding(Mil.): | 31.98 |
Dividend: | -- |
Yield (%): | -- |
Financials
BAVA.CO | Industry | Sector | |
---|---|---|---|
P/E (TTM): | 40.08 | 30.48 | 33.70 |
EPS (TTM): | 7.25 | -- | -- |
ROI: | 11.17 | 14.95 | 14.45 |
ROE: | 11.48 | 16.27 | 15.96 |